Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes

Status Completed

Clinical Trial Summary

Lipoprotein-associated phospholipase A2 (LP-PLA2) is a good marker of cardiovascular risk and inflammation. This study aims at the characteristic and clinical significance of LP-PLA2 test in patients with type 2 diabetes(T2D).

Clinical Trial Description

The investigators recorded clinical factors, serum levels of glucose, HbA1c, lipids and LP-PLA2 in patients with T2D who visited in the Department of Endocrinology at the Nanjing First Hospital from January 2015 to August 2016. The relationship between levels of LP-PLA2 and diabetic complications are analysed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03362112
Study type	Observational
Source	Nanjing First Hospital, Nanjing Medical University
Contact
Status	Completed
Phase
Start date	January 30, 2015
Completion date	June 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03239366` - A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population	Phase 2
Completed	`NCT04597229` - Efficacy of Multigrain Supplementation in Type II Diabetes Mellitus	N/A
Completed	`NCT03623139` - Effects of Basic Carbohydrate Counting Versus Standard Outpatient Nutritional Education in Type 2 Diabetes	N/A
Active, not recruiting	`NCT04599920` - Effects of Replacing Red Meat With Legumes on Biomarkers of Chronic Diseases in Healthy Men (Leg4Life)	N/A
Active, not recruiting	`NCT03422471` - Hypoglycemia and Autonomic Nervous System Function- B2	N/A
Completed	`NCT04382521` - A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions	N/A
Recruiting	`NCT04564391` - Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins	N/A
Recruiting	`NCT03458715` - The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin	Phase 4
Terminated	`NCT03278236` - Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?	N/A
Completed	`NCT02974504` - Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)	Phase 4
Completed	`NCT05053828` - Type 2 Diabetes With Antiplatelet Drugs
Not yet recruiting	`NCT03659383` - The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With Glargine	Phase 4
Completed	`NCT03542240` - Effects of Curcumin Supplementation on Gut Barrier Function in Patients With Metabolic Syndrome	N/A
Completed	`NCT03657537` - Effects of Ketone Bodies on Cognition in Type 2 Diabetes	Phase 1
Completed	`NCT03979768` - Risk Assessment of Type 2 Diabetes in Pharmacies	N/A
Completed	`NCT03614039` - Effect of Probiotic and Smectite Gel on NAFLD	N/A
Active, not recruiting	`NCT04994288` - A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients	Phase 2/Phase 3
Completed	`NCT03290768` - Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)	N/A
Enrolling by invitation	`NCT04088851` - "The Role of the Liver for Interorgan Metabolic Crosstalk in Type 2 Diabetes"	N/A
Completed	`NCT03643783` - Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients